Authors: Delaugerre, C Mouroux, M Yvon-Groussin, A Simon, A Angleraud, F Huraux, JM Agut, H Katlama, C Calvez, V

Citation: C. Delaugerre et al., Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice, ANTIM AG CH, 45(3), 2001, pp. 946-948

Authors: Yvon-Groussin, A Mugnier, P Bertin, P Grandadam, M Agut, H Huraux, JM Calvez, V

Citation: A. Yvon-groussin et al., Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure, J VIROLOGY, 75(15), 2001, pp. 7184-7187

Authors: Mouroux, M Izopet, J Descamps, D Delaugerre, C Yvon-Groussin, A Angleraud, F Coutellier, A Bonmarchand, M Valantin, MA Matheron, S Agut, H Katlama, C Brun-Vezinet, F Calvez, V

Citation: M. Mouroux et al., Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T., PATH BIOL, 48(5), 2000, pp. 508-512

Authors: Mouroux, M Yvon-Groussin, A Peytavin, G Delaugerre, C Legrand, M Bossi, P Do, B Trylesinski, A Diquet, B Dohin, E Delfraissy, JF Katlama, C Calvez, V

Citation: M. Mouroux et al., Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance, J CLIN MICR, 38(7), 2000, pp. 2726-2730

Authors: Mouroux, M Bossi, P Yvon-Groussin, A Delaugerre, C Valantin, MA Tubiana, R Coutellier, A Bonmarchand, M Bricaire, F Katlama, C Agut, H Huraux, JM Calvez, V

Citation: M. Mouroux et al., Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor., PATH BIOL, 47(5), 1999, pp. 549-552